FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157450847> ?p ?o ?g. }

• W2157450847 endingPage "1293" @default.
• W2157450847 startingPage "1293" @default.
• W2157450847 abstract "The interactions between the tumor microenvironment and tumor cells determine the behavior of the primary tumors. Whether cancer-associated fibroblasts (CAF) have a tumor progressive or a protective role likely depends on the type of tumor cells and the CAF subpopulation. In the present study, we analyzed the prognostic significance of CAF subpopulations in colorectal cancer (CRC). CAF phenotypes were analyzed in 302 CRC patients by using antibodies against podoplanin (PDPN), α-smooth muscle actin (α-SMA), and S100A4. The relationship between the CAF phenotypes and 11 clinicopathological parameters were evaluated and their prognostic significance was analyzed from the disease-free and overall survival times. We observed that at the tumor invasive front, PDPN CAFs were present in 40% of the cases, and S100A4 or α-SMA CAFs were detected in all the cases. PDPN/S100A4 and α-SMA/S100A4 dual-stained CAFs were observed in 10% and 40% of the cases, respectively. The PDPN(+) CAFs were associated with 6 favorable clinicopathological parameters and prolonged disease-free survival time. The PDPN(-)/α-SMA(high) CAFs were associated with 6 aggressive clinicopathological parameters and tended to exhibit shorter disease-free survival time. On the other hand, the PDPN(-)/S100A4(high) CAFs were associated with 2 tumor progression parameters, but not with disease prognosis. The PDPN(+) CAF phenotype is distinct from the α-SMA or S100A4 CAFs in that it is associated with less aggressive tumors and a favorable prognosis, whereas the PDPN(-)/α-SMA(high) or PDPN(-)/S100A4(high) CAFs are associated with tumor progression in CRC. These findings suggest that CAFs can be a useful prognostic biomarker or potential targets of anti-cancer therapy in CRC." @default.
• W2157450847 created "2016-06-24" @default.
• W2157450847 creator A5000021239 @default.
• W2157450847 creator A5000492660 @default.
• W2157450847 creator A5010662746 @default.
• W2157450847 creator A5016610061 @default.
• W2157450847 creator A5021127690 @default.
• W2157450847 creator A5027317322 @default.
• W2157450847 creator A5060345927 @default.
• W2157450847 creator A5063394974 @default.
• W2157450847 creator A5072393058 @default.
• W2157450847 creator A5091253344 @default.
• W2157450847 date "2013-01-01" @default.
• W2157450847 modified "2023-10-15" @default.
• W2157450847 title "Podoplanin, α-Smooth Muscle Actin or S100A4 Expressing Cancer-Associated Fibroblasts Are Associated with Different Prognosis in Colorectal Cancers" @default.
• W2157450847 cites W109896574 @default.
• W2157450847 cites W1706217827 @default.
• W2157450847 cites W1778276096 @default.
• W2157450847 cites W1964507798 @default.
• W2157450847 cites W1980193533 @default.
• W2157450847 cites W1989025666 @default.
• W2157450847 cites W2002524603 @default.
• W2157450847 cites W2009230738 @default.
• W2157450847 cites W2010557523 @default.
• W2157450847 cites W2012885850 @default.
• W2157450847 cites W2020505509 @default.
• W2157450847 cites W2031611276 @default.
• W2157450847 cites W2041123705 @default.
• W2157450847 cites W2054398355 @default.
• W2157450847 cites W2058481603 @default.
• W2157450847 cites W2075465677 @default.
• W2157450847 cites W2078128014 @default.
• W2157450847 cites W2087045011 @default.
• W2157450847 cites W2089638475 @default.
• W2157450847 cites W2089956125 @default.
• W2157450847 cites W2124154627 @default.
• W2157450847 cites W2128793721 @default.
• W2157450847 cites W2139429843 @default.
• W2157450847 cites W2170866914 @default.
• W2157450847 doi "https://doi.org/10.3346/jkms.2013.28.9.1293" @default.
• W2157450847 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3763102" @default.
• W2157450847 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24015033" @default.
• W2157450847 hasPublicationYear "2013" @default.
• W2157450847 type Work @default.
• W2157450847 sameAs 2157450847 @default.
• W2157450847 citedByCount "47" @default.
• W2157450847 countsByYear W21574508472016 @default.
• W2157450847 countsByYear W21574508472017 @default.
• W2157450847 countsByYear W21574508472018 @default.
• W2157450847 countsByYear W21574508472019 @default.
• W2157450847 countsByYear W21574508472020 @default.
• W2157450847 countsByYear W21574508472021 @default.
• W2157450847 countsByYear W21574508472022 @default.
• W2157450847 countsByYear W21574508472023 @default.
• W2157450847 crossrefType "journal-article" @default.
• W2157450847 hasAuthorship W2157450847A5000021239 @default.
• W2157450847 hasAuthorship W2157450847A5000492660 @default.
• W2157450847 hasAuthorship W2157450847A5010662746 @default.
• W2157450847 hasAuthorship W2157450847A5016610061 @default.
• W2157450847 hasAuthorship W2157450847A5021127690 @default.
• W2157450847 hasAuthorship W2157450847A5027317322 @default.
• W2157450847 hasAuthorship W2157450847A5060345927 @default.
• W2157450847 hasAuthorship W2157450847A5063394974 @default.
• W2157450847 hasAuthorship W2157450847A5072393058 @default.
• W2157450847 hasAuthorship W2157450847A5091253344 @default.
• W2157450847 hasBestOaLocation W21574508471 @default.
• W2157450847 hasConcept C114614502 @default.
• W2157450847 hasConcept C121608353 @default.
• W2157450847 hasConcept C126322002 @default.
• W2157450847 hasConcept C142724271 @default.
• W2157450847 hasConcept C143998085 @default.
• W2157450847 hasConcept C161921814 @default.
• W2157450847 hasConcept C204232928 @default.
• W2157450847 hasConcept C2776107976 @default.
• W2157450847 hasConcept C2779256057 @default.
• W2157450847 hasConcept C2909316934 @default.
• W2157450847 hasConcept C2909706936 @default.
• W2157450847 hasConcept C33923547 @default.
• W2157450847 hasConcept C502942594 @default.
• W2157450847 hasConcept C526805850 @default.
• W2157450847 hasConcept C71924100 @default.
• W2157450847 hasConceptScore W2157450847C114614502 @default.
• W2157450847 hasConceptScore W2157450847C121608353 @default.
• W2157450847 hasConceptScore W2157450847C126322002 @default.
• W2157450847 hasConceptScore W2157450847C142724271 @default.
• W2157450847 hasConceptScore W2157450847C143998085 @default.
• W2157450847 hasConceptScore W2157450847C161921814 @default.
• W2157450847 hasConceptScore W2157450847C204232928 @default.
• W2157450847 hasConceptScore W2157450847C2776107976 @default.
• W2157450847 hasConceptScore W2157450847C2779256057 @default.
• W2157450847 hasConceptScore W2157450847C2909316934 @default.
• W2157450847 hasConceptScore W2157450847C2909706936 @default.
• W2157450847 hasConceptScore W2157450847C33923547 @default.
• W2157450847 hasConceptScore W2157450847C502942594 @default.
• W2157450847 hasConceptScore W2157450847C526805850 @default.
• W2157450847 hasConceptScore W2157450847C71924100 @default.
• W2157450847 hasFunder F4320322034 @default.
• W2157450847 hasIssue "9" @default.

• next